Aortic stenosis affects more than 9 million people worldwide and is commonly treated with surgical aortic valve replacement (SAVR), which is known for producing excellent long-term outcomes. Recent advancements in transcatheter aortic valve replacement (TAVR) have shown noninferior or improved outcomes compared to SAVR across various risk levels.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transcatheter
October 3, 2024
October 2, 2024
In June 2024, a panel of cardiothoracic surgery experts gathered at Teatro delle Muse in Ancona, Italy to discuss Minimally Invasive and Trans-Catheter Interventions for patients with Mitral and Tricuspid Valve Diseases. This course was directed by Professor Marco Di Eusanio.
September 12, 2024
Researchers explore the use of a novel transcatheter electrosurgical technique, SESAME, for treating left ventricular outflow tract (LVOT) obstruction. This procedure, designed to mimic surgical myotomy, was tested on 76 patients between 2021 and 2023.
Surgical Extraction of a Watchman Device, Amplatzer Plug, and Failed Transcatheter Mitral Prosthesis
August 26, 2024
This video demonstrates the surgical extraction of a Watchman device, Amplatzer occluder, and a failed transcatheter mitral prosthesis on a seventy-eight-year-old male.
July 11, 2024
The number of patients at intermediate and low surgical risk treated by transcatheter aortic valve implantation (TAVI) is rapidly increasing. Current guidelines recommend performing TAVI in heart valve centers with surgical backup.
June 27, 2024
This video is a balanced, gripping presentation on an increasingly common emergency problem for the on-call cardiac surgeon. Professor Oo discusses the evolving landscape of surgery for acute De Bakey I and II pathologies of the aortic organ.
June 5, 2024
Surgical explantation of transcatheter heart valves (THV) is rapidly increasing, but data on patients with THV-associated infective endocarditis (IE) is lacking. This study assessed the outcomes of patients undergoing THV explant for IE based on data from the international TAVR-EXPLANT Registry.
May 23, 2024
The NOTION-2 trial aimed to compare transcatheter aortic valve implantation (TAVI) with surgical aortic valve replacement (SAVR) in low-risk patients less than 75 years old, including with both tricuspid and bicuspid aortic stenosis (AS).
May 18, 2024
Succinct but comprehensive expert viewpoint on Support in Cardiogenic Shock vis -a -vis the manuscript of DanGer trial on promising results of Impella in highly selected subgroup (360 patients in a decade). The important point made is that of careful selection
April 22, 2024
With the recent approval for transcatheter aortic valve replacement (TAVR) across all risk profiles, reintervention is likely to become common practice.